Jump to content

Wikipedia:Choosing Wisely/American Society of Nephrology: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Dexbot (talk | contribs)
Bots
192,594 edits
m Bot: Deprecating Template:Cite doi and some minor fixes
Dexbot (talk | contribs)
Bots
192,594 edits
m Bot: Deprecating Template:Cite pmid and some minor fixes
Line 184: Line 184:
#<!-- 1 -->
#<!-- 1 -->
#*
#*
*<ref name="ESRDcancer">{{Cite journal | doi = 10.1016/S0140-6736(99)06154-1 | last1 = Maisonneuve | first1 = P. | last2 = Agodoa | first2 = L. | last3 = Gellert | first3 = R. | last4 = Stewart | first4 = J. H. | last5 = Buccianti | first5 = G. | last6 = Lowenfels | first6 = A. B. | last7 = Wolfe | first7 = R. A. | last8 = Jones | first8 = E. | last9 = Disney | first9 = A. P. | last10 = Briggs | first10 = D. | last11 = McCredie | first11 = M. | last12 = Boyle | first12 = P. | title = Cancer in patients on dialysis for end-stage renal disease: An international collaborative study | journal = Lancet | volume = 354 | issue = 9173 | pages = 93–99 | year = 1999 | pmid = 10408483}}</ref>
*<ref name="ESRDcancer">{{cite PMID|10408483}}</ref>
*<ref name="ESRDcancerfinancal">{{Cite journal | last1 = Chertow | first1 = G. M. | last2 = Paltiel | first2 = A. D. | last3 = Owen | first3 = W. F. | last4 = Lazarus | first4 = J. M. | title = Cost-effectiveness of Cancer Screening in End-Stage Renal Disease | doi = 10.1001/archinte.1996.00440110117016 | journal = Archives of Internal Medicine | volume = 156 | issue = 12 | pages = 1345–1350 | year = 1996 | pmid = 8651845| pmc = }}</ref>
*<ref name="ESRDcancerfinancal">{{Cite journal | last1 = Chertow | first1 = G. M. | last2 = Paltiel | first2 = A. D. | last3 = Owen | first3 = W. F. | last4 = Lazarus | first4 = J. M. | title = Cost-effectiveness of Cancer Screening in End-Stage Renal Disease | doi = 10.1001/archinte.1996.00440110117016 | journal = Archives of Internal Medicine | volume = 156 | issue = 12 | pages = 1345–1350 | year = 1996 | pmid = 8651845| pmc = }}</ref>
*<ref name="ESAforchronkid">{{Cite journal | last1 = Palmer | first1 = S. C. | last2 = Navaneethan | first2 = S. D. | last3 = Craig | first3 = J. C. | last4 = Johnson | first4 = D. W. | last5 = Tonelli | first5 = M. | last6 = Garg | first6 = A. X. | last7 = Pellegrini | first7 = F. | last8 = Ravani | first8 = P. | last9 = Jardine | first9 = M. | last10 = Perkovic | first10 = V. | last11 = Graziano | first11 = G. | last12 = McGee | first12 = R. | last13 = Nicolucci | first13 = A. | last14 = Tognoni | first14 = G. | last15 = Strippoli | first15 = G. F. | title = Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease | journal = Annals of internal medicine | volume = 153 | issue = 1 | pages = 23–33 | year = 2010 | doi = 10.1059/0003-4819-153-1-201007060-00252 | pmid = 20439566 | pmc = }}</ref>
*<ref name="ESAforchronkid">{{cite PMID|20439566}}</ref>
*<ref name="2007anemiaESA">{{Cite journal | last1 = Aapro | first1 = M. S. | last2 = Link | first2 = H. | doi = 10.1634/theoncologist.13-S3-33 | title = September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents | journal = The Oncologist | volume = 13 | pages = 33–36 | year = 2008 | pmid = 18458123| pmc = }}</ref>
*<ref name="2007anemiaESA">{{Cite journal | last1 = Aapro | first1 = M. S. | last2 = Link | first2 = H. | doi = 10.1634/theoncologist.13-S3-33 | title = September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents | journal = The Oncologist | volume = 13 | pages = 33–36 | year = 2008 | pmid = 18458123| pmc = }}</ref>
*<ref name="KDOQI">{{cite journal|last=National Kidney Foundation|title=Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification|journal=Am J Kidney Dis|year=2002|volume=39|series=Kidney Disease Outcomes Quality Initiative|issue=S1-S000|url=http://www.kidney.org/professionals/kdoqi/guidelines_ckd/toc.htm|accessdate=26 September 2012}}</ref>
*<ref name="KDOQI">{{cite journal|last=National Kidney Foundation|title=Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification|journal=Am J Kidney Dis|year=2002|volume=39|series=Kidney Disease Outcomes Quality Initiative|issue=S1-S000|url=http://www.kidney.org/professionals/kdoqi/guidelines_ckd/toc.htm|accessdate=26 September 2012}}</ref>
*<ref name="RenalAssnUK">{{cite web|title=Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral|url=http://www.renal.org/ckdguide/full/ukckdfull.pdf|publisher=[[Renal Association]]|accessdate=26 September 2012|author1=Royal College of Physicians|authorlink1=Royal College of Physicians|author2=Renal Association|authorlink2=Renal Association|year=c. 2005}}</ref>
*<ref name="RenalAssnUK">{{cite web|title=Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral|url=http://www.renal.org/ckdguide/full/ukckdfull.pdf|publisher=[[Renal Association]]|accessdate=26 September 2012|author1=Royal College of Physicians|authorlink1=Royal College of Physicians|author2=Renal Association|authorlink2=Renal Association|year=c. 2005}}</ref>
*<ref name="seventh">{{Cite journal | last1 = Chobanian | first1 = A. V. | last2 = Bakris | first2 = G. L. | last3 = Black | first3 = H. R. | last4 = Cushman | first4 = W. C. | last5 = Green | first5 = L. A. | last6 = Izzo Jr. | first6 = J. L. | last7 = Jones | first7 = D. W. | last8 = Materson | first8 = B. J. | last9 = Oparil | first9 = S. | last10 = Wright Jr. | first10 = J. T. | last11 = Roccella | first11 = E. J. | author12 = the National High Blood Pressure Education Program Coordinating Committee| title = Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | doi = 10.1161/01.HYP.0000107251.49515.c2 | journal = Hypertension | volume = 42 | issue = 6 | pages = 1206–1252 | year = 2003 | pmid = 14656957 | pmc = }}</ref>
*<ref name="seventh">{{cite PMID|14656957}}</ref>
*<ref name="scottish">{{cite book|first=Scottish Intercollegiate Guidelines Network|title=Management of chronic heart failure : a national clinical guideline.|url=http://www.sign.ac.uk/guidelines/fulltext/95/index.html|year=2007|publisher=Scottish Intercollegiate Guidelines Network|location=Edinburgh|isbn=1899893946}}</ref>
*<ref name="scottish">{{cite book|first=Scottish Intercollegiate Guidelines Network|title=Management of chronic heart failure : a national clinical guideline.|url=http://www.sign.ac.uk/guidelines/fulltext/95/index.html|year=2007|publisher=Scottish Intercollegiate Guidelines Network|location=Edinburgh|isbn=1899893946}}</ref>
*<ref name="venous">{{Cite journal | last1 = Hoggard | first1 = J. | last2 = Saad | first2 = T. | last3 = Schon | first3 = D. | last4 = Vesely | first4 = T. M. | last5 = Royer | first5 = T. | last6 = American Society Of Diagnostic Interventional Nephrology | first6 = C. P. C. | last7 = Association For Vascular | first7 = A. | title = Guidelines for Venous Access in Patients with Chronic Kidney Disease | doi = 10.1111/j.1525-139X.2008.00421.x | journal = Seminars in Dialysis | volume = 21 | issue = 2 | pages = 186–191 | year = 2008 | pmid = 18364015 | pmc = }}</ref>
*<ref name="venous">{{cite PMID|18364015}}</ref>
*<ref name="patientperspective">{{Cite journal | last1 = Singer | first1 = P. A. | title = Quality End-of-Life Care: Patients' Perspectives | doi = 10.1001/jama.281.2.163 | journal = JAMA: the Journal of the American Medical Association | volume = 281 | issue = 2 | pages = 163 | year = 1999 | pmid = | pmc = }}</ref>
*<ref name="patientperspective">{{Cite journal | last1 = Singer | first1 = P. A. | title = Quality End-of-Life Care: Patients' Perspectives | doi = 10.1001/jama.281.2.163 | journal = JAMA: the Journal of the American Medical Association | volume = 281 | issue = 2 | pages = 163 | year = 1999 | pmid = | pmc = }}</ref>
{{collapse bottom}}
{{collapse bottom}}

Revision as of 18:34, 3 December 2015

This project shares information from the American Society of Nephrology on Wikipedia.

Articles of interest

Articles relating to American Society of Nephrology content
article traffic pageview count* pageview date* example change sources cited change summary
American Society of Nephrology chart 377 03 Aug 12
Cancer screening chart 2152 03 Aug 12 history [1][2] added an entry to a list of situations when not to screen
Dialysis chart 86063 03 Aug 12
Chronic kidney disease chart 63800 03 Aug 12 history [1][2][3] added info about increased risk of cancer and recommendation not to cancer screen
Mammography chart 29144 03 Aug 12
Prostate-specific antigen chart 33336 03 Aug 12
Erythropoiesis-stimulating agent chart 938 03 Aug 12 history [1][4] added indications section
Hemoglobin chart 117363 03 Aug 12
Anemia chart 196810 03 Aug 12 history [1][4] added ESA to list of treatments and stated when ESA ought not be used
Blood transfusion chart 39920 03 Aug 12
Non-steroidal anti-inflammatory drug chart 73303 03 Aug 12
Hypertension chart 158524 03 Aug 12
Heart failure chart 99595 03 Aug 12
Diabetes mellitus chart 213131 03 Aug 12
Peripherally inserted central catheter chart 26643 03 Aug 12
Nephrology chart 45073 03 Aug 12
Arteriovenous fistula chart 12035 03 Aug 12
Hemodialysis chart 37931 03 Aug 12
Graft (surgery) chart 1681 03 Aug 12
Catheter chart 66548 03 Aug 12
  • *page views are for the 30-day period ending on the date checked

Sources

edit this section to edit references


American Society of Nephrology (24 April 2014), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American Society of Nephrology, retrieved 15 September 2014, which cites

  1. ^ a b c d Cite error: The named reference ASNfive was invoked but never defined (see the help page).
  2. ^ a b c Chertow, G. M.; Paltiel, A. D.; Owen, W. F.; Lazarus, J. M. (1996). "Cost-effectiveness of Cancer Screening in End-Stage Renal Disease". Archives of Internal Medicine. 156 (12): 1345–1350. doi:10.1001/archinte.1996.00440110117016. PMID 8651845.
  3. ^ a b Maisonneuve, P.; Agodoa, L.; Gellert, R.; Stewart, J. H.; Buccianti, G.; Lowenfels, A. B.; Wolfe, R. A.; Jones, E.; Disney, A. P.; Briggs, D.; McCredie, M.; Boyle, P. (1999). "Cancer in patients on dialysis for end-stage renal disease: An international collaborative study". Lancet. 354 (9173): 93–99. doi:10.1016/S0140-6736(99)06154-1. PMID 10408483.
  4. ^ a b c Aapro, M. S.; Link, H. (2008). "September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents". The Oncologist. 13: 33–36. doi:10.1634/theoncologist.13-S3-33. PMID 18458123.
  5. ^ Palmer, S. C.; Navaneethan, S. D.; Craig, J. C.; Johnson, D. W.; Tonelli, M.; Garg, A. X.; Pellegrini, F.; Ravani, P.; Jardine, M.; Perkovic, V.; Graziano, G.; McGee, R.; Nicolucci, A.; Tognoni, G.; Strippoli, G. F. (2010). "Meta-analysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease". Annals of internal medicine. 153 (1): 23–33. doi:10.1059/0003-4819-153-1-201007060-00252. PMID 20439566.
  6. ^ National Kidney Foundation (2002). "Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification and Stratification". Am J Kidney Dis. Kidney Disease Outcomes Quality Initiative. 39 (S1 – S000). Retrieved 26 September 2012.
  7. ^ Royal College of Physicians; Renal Association (c. 2005). "Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral" (PDF). Renal Association. Retrieved 26 September 2012.
  8. ^ Chobanian, A. V.; Bakris, G. L.; Black, H. R.; Cushman, W. C.; Green, L. A.; Izzo Jr., J. L.; Jones, D. W.; Materson, B. J.; Oparil, S.; Wright Jr., J. T.; Roccella, E. J.; the National High Blood Pressure Education Program Coordinating Committee (2003). "Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure". Hypertension. 42 (6): 1206–1252. doi:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957.
  9. ^ Management of chronic heart failure : a national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network. 2007. ISBN 1899893946. {{cite book}}: |first= missing |last= (help)
  10. ^ Hoggard, J.; Saad, T.; Schon, D.; Vesely, T. M.; Royer, T.; American Society Of Diagnostic Interventional Nephrology, C. P. C.; Association For Vascular, A. (2008). "Guidelines for Venous Access in Patients with Chronic Kidney Disease". Seminars in Dialysis. 21 (2): 186–191. doi:10.1111/j.1525-139X.2008.00421.x. PMID 18364015.
  11. ^ Singer, P. A. (1999). "Quality End-of-Life Care: Patients' Perspectives". JAMA: the Journal of the American Medical Association. 281 (2): 163. doi:10.1001/jama.281.2.163.
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Wikipedia:Choosing_Wisely/American_Society_of_Nephrology&oldid=693614044"